Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
Our on-demand webinar covers recent accounting pronouncements and updates, the SEC’s evolving agenda, and provides year-end accounting, reporting,and tax reminders to keep you on track through the close of 2024.
Learn how ASU 2023-09 enhances income tax disclosures with new rate reconciliation and cash flow reporting requirements for public entities.
Weaver’s overview of the SEC’s 2025 examination priorities describe practices by investment advisers and others that may come under SEC review.
Weaver professionals discuss the U.S. Supreme Court’s decision to overturn the Chevron doctrine, cybersecurity and accounting reminders on goodwill impairment.
Boards and management may want to consider how recent Fed activity, election uncertainty, and emerging ERP considerations will affect their businesses.
Download Weaver's ESG Report to learn about our commitment to operating openly, ethically and transparently as a firm that is focused on the future.
Weaver's public company practice discusses recent accounting pronouncements and updates, as well as the SEC’s agenda and the effect which these may have on your company’s financial reporting.
The home health and hospice sectors are facing significant challenges with personal care emerging as the key sector for mitigating risk.
Weaver’s second quarterly Accounting and SEC Update of 2024 covered stock compensation and other standards updates, filer status assessments and recent SEC/ PCAOB enforcement actions.
Weaver offers information and insights to help you ask the right questions and determine appropriate plans of action based on topics and trends as they unfold.
When is a valuation allowance needed in a company’s financial statement? Find out more about valuing deferred tax assets in financial statements.
1 2 3 4 23